Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Karonudib Has Potent Anti-Tumor Effects in Preclinical Models of B-Cell Lymphoma

Morten P Oksvold, PhD MSC, Ulrika Warpman Berglund, PhD, Helge Gad, PhD, Baoyan Bai, PhD, Trond Stokke, PhD, Idun D Rein, Msc, Therese Pham, Kumar Sanjiv, PhD, Geir Frode Øy, PhD, Jens Henrik Norum, PhD, Erlend B. Smeland, PhD MD, June Helen Myklebust, PhD, Thomas Helleday, PhD, Thea Kristin Våtsveen, PhD

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-140943

Published: 2020

Journal Articles

Heterogeneity of Regulatory T Cells in B-Cell Non-Hodgkin Lymphoma

Ivana Spasevska, Sarah Josefsson, PhD MSc, Yngvild Nuvin Blaker, MD PhD, Chloe B. Steen, PhD, Ankush Sharma, PhD, Kushi Kushekhar, PhD MSc, Saskia Meyer, PhD, Arne Kolstad, MD PhD, Klaus Beiske, MD PhD, Harald Holte, MD PhD, Bjørn Østenstad, MD PhD, Eva Kimby, MD PhD, Johanna Olweus, PhD, Kjetil Tasken, PhD, Suzanne Lorenz, PhD, Erlend B. Smeland, PhD MD, Ash A. Alizadeh, MD PhD, Kanutte Huse, PhD, June Helen Myklebust, PhD

Blood (2020) 136 (Supplement 1): 27–28.

https://doi.org/10.1182/blood-2020-142380

Published: 2020

Journal Articles

An Atlas of Clinically-Distinct Tumor Cellular Ecosystems in Diffuse Large B Cell Lymphoma

Chloe B. Steen, MSc, Bogdan A. Luca, PhD, Mohammad Shahrokh Esfahani, Barzin Y. Nabet, PhD, Brian Sworder, MD PhD, Farshad Farshidfar, MD PhD, Kiarash Shamardani, BA, David M. Kurtz, MD PhD, Chih Long Liu, PhD, Ranjana H Advani, MD, Yasodha Natkunam, MD PhD, June Helen Myklebust, PhD, Maximilian Diehn, MD PhD, Andrew Gentles, PhD, Aaron M Newman, PhD, Ash A. Alizadeh, MD PhD

Blood (2019) 134 (Supplement_1): 655.

https://doi.org/10.1182/blood-2019-129461

Published: 2019

Journal Articles

Deep Profiling of Genetic Aberrations and Clonal Evolution in Follicular Lymphoma

Baoyan Bai, PhD, Daniel Vodák, BS, Sigve Nakken, PhD, Jillian F. Wise, PhD, Yngvild Nuvin Blaker, MD PhD, Ole Christian Lingjærde, PhD, Marianne Brodtkorb, MD PhD, Vera Hilden, Gunhild Trøen, Suzanne Lorenz, PhD, Michael S. Lawrence, PhD, Ola Myklebost, PhD, Leonardo Meza-Zepeda, PhD, Klaus Beiske, MD PhD, Eivind Hovig, PhD, Erlend B. Smeland, MD PhD, Harald Holte, MD PhD, June Helen Myklebust, PhD

Blood (2019) 134 (Supplement_1): 20.

https://doi.org/10.1182/blood-2019-128403

Published: 2019

Journal Articles

Mutational Dynamics and Evolutionary Divergence in DLBCL: A Call for Relapse Sampling

Blood (2019) 134 (Supplement_1): 1497.

https://doi.org/10.1182/blood-2019-131072

Published: 2019

Journal Articles

The DLBCL90 Double-Hit Gene Expression Signature Is Not Associated with Inferior Survival in Young High-Risk Patients with Diffuse Large B-Cell Lymphoma Treated with Dose-Intensive Immunochemotherapy

Kathrine T. Isaksen, MD, Klaus Beiske, MD PhD, Erlend B. Smeland, MD PhD, Judit Jørgensen, MD PhD, Marianne Brodtkorb, MD PhD, June Helen Myklebust, PhD, Mats Jerkeman, MD Professor, Leo Meriranta, MD, Marja-Liisa Karjalainen-Lindsberg, MD PhD, Sirpa Leppa, MD PhD, David W. Scott, MBChB, PhD, Harald Holte, MD PhD, Yngvild Nuvin Blaker, MD PhD

Blood (2019) 134 (Supplement_1): 1485.

https://doi.org/10.1182/blood-2019-121467

Published: 2019

Journal Articles

Combined Clinical and Gene Expression Score Identifies Follicular Lymphoma Patients with High Risk of Transformation in the Rituximab Era

Chloe Beate Steen, Ellen Leich, June Helen Myklebust, PhD, Sandra Lockmer, Jillian Frances Wise, Björn Engelbrekt Wahlin, Bjørn Østenstad, Knut Liestol, Eva Kimby, Andreas Rosenwald, Erlend Bremertun Smeland, Harald Holte, Ole Christian Lingjærde, Marianne Brodtkorb

Blood (2017) 130 (Supplement 1): 1467.

https://doi.org/10.1182/blood.V130.Suppl_1.1467.1467

Published: 2017

Journal Articles

Identification of Tigit on Intra-Tumor T Cells As a New Target for Immune Checkpoint Blockade in Follicular Lymphoma

Sarah Gothberg, Kanutte Huse, Arne Kolstad, MD PhD, Ole Christian Lingjærde, PhD, Bjørn Østenstad, MD PhD, Erlend Smeland, MD PhD, Ronald Levy, MD, Jonathan Michael Irish, PhD, June Helen Myklebust, PhD

Blood (2016) 128 (22): 917.

https://doi.org/10.1182/blood.V128.22.917.917

Published: 2016

Journal Articles

Discovery of Recurrent Mutations Associated with Chemo-Immunotherapy Relapse in Diffuse Large B-Cell Lymphoma

Jillian Frances Wise, PhD, Sigve Nakken, PhD, Daniel Vodak, BS, Gunhild Trøen, PhD, Ole Christian Lingjærde, PhD, Leonardo A. Meza-Zepeda, PhD, Ola Myklebost, PhD, Klaus Beiske, MD PhD, June Helen Myklebust, PhD, Eivind Hovig, PhD, Erlend Smeland, MD PhD, Harald Holte, Jr., MD PhD

Blood (2015) 126 (23): 110.

https://doi.org/10.1182/blood.V126.23.110.110

Published: 2015

Journal Articles

Potentiated B-Cell Antigen Receptor Signaling In Mantle Cell Lymphoma Is Associated With Overexpression Of Surface CD79B and IgM

June Helen Myklebust, PhD, Joshua Brody, MD, Ash A. Alizadeh, MD, PhD, Debra K Czerwinski, Arne Kolstad, MD, PhD, Michael R Green, Ph.D., Roch Houot, MD, PhD, Jan Delabie, MD, PhD, Holbrook E Kohrt, MD, PhD, Jonathan M. Irish, PhD, Ronald Levy, MD

Blood (2013) 122 (21): 1768.

https://doi.org/10.1182/blood.V122.21.1768.1768

Published: 2013

Journal Articles

Prediction of Survival In Diffuse Large B-Cell Lymphoma Based On the Expression of Two Genes Reflecting Tumor and Microenvironment

Ash A. Alizadeh, MD/PhD, Andrew J. Gentles, Ph.D., Alvaro J. Alencar, MD, Holbrook E Kohrt, MD, Roch Houot, MD/PhD, Matthew J Goldstein, BA, Shuchun Zhao, Ph.D., Yasodha Natkunam, MD, PhD, Ranjana Advani, MD, Randy D. Gascoyne, MD, Javier Briones, MD, Robert J. Tibshirani, Ph.D., June Helen Myklebust, PhD, Sylvia K. Plevritis, PhD, Izidore S Lossos, MD, Ronald Levy, MD

Blood (2010) 116 (21): 2006.

https://doi.org/10.1182/blood.V116.21.2006.2006

Published: 2010

Journal Articles

NF-κB Signaling In Response to CpG Stratifies Mantle Cell Lymphoma Patient Outcome

June Helen Myklebust, PhD, Jonathan Michael Irish, PhD, Joshua Brody, MD, Ash A. Alizadeh, MD/PhD, Debra Czerwinski, Roch Houot, MD, PhD, Holbrook E Kohrt, MD, Arne Kolstad, MD, PhD, Ronald Levy, MD

Blood (2010) 116 (21): 144.

https://doi.org/10.1182/blood.V116.21.144.144

Published: 2010

Journal Articles

Therapeutic Antibody Targeting of CD47 Synergizes with Rituximab to Completely Eradicate Human B-Cell Lymphoma Xenografts.

Mark P. Chao, BA, Ash A Alizadeh, MD, PhD, Chad Z. Tang, MS, June Helen Myklebust, PhD, Bindu Varghese, PhD, Max Jan, BA, Ronald Levy, MD, Irving L. Weissman, MD, Ravindra Majeti, MD, PhD

Blood (2009) 114 (22): 2716.

https://doi.org/10.1182/blood.V114.22.2716.2716

Published: 2009

NARROW

Karonudib Has Potent Anti-Tumor Effects in Preclinical Models of B-Cell Lymphoma

Heterogeneity of Regulatory T Cells in B-Cell Non-Hodgkin Lymphoma

An Atlas of Clinically-Distinct Tumor Cellular Ecosystems in Diffuse Large B Cell Lymphoma

Deep Profiling of Genetic Aberrations and Clonal Evolution in Follicular Lymphoma

Mutational Dynamics and Evolutionary Divergence in DLBCL: A Call for Relapse Sampling

The DLBCL90 Double-Hit Gene Expression Signature Is Not Associated with Inferior Survival in Young High-Risk Patients with Diffuse Large B-Cell Lymphoma Treated with Dose-Intensive Immunochemotherapy

Combined Clinical and Gene Expression Score Identifies Follicular Lymphoma Patients with High Risk of Transformation in the Rituximab Era

Identification of Tigit on Intra-Tumor T Cells As a New Target for Immune Checkpoint Blockade in Follicular Lymphoma

Discovery of Recurrent Mutations Associated with Chemo-Immunotherapy Relapse in Diffuse Large B-Cell Lymphoma

Potentiated B-Cell Antigen Receptor Signaling In Mantle Cell Lymphoma Is Associated With Overexpression Of Surface CD79B and IgM

Prediction of Survival In Diffuse Large B-Cell Lymphoma Based On the Expression of Two Genes Reflecting Tumor and Microenvironment

NF-κB Signaling In Response to CpG Stratifies Mantle Cell Lymphoma Patient Outcome

Therapeutic Antibody Targeting of CD47 Synergizes with Rituximab to Completely Eradicate Human B-Cell Lymphoma Xenografts.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only